Search results
MIRA reports promising Ketamir-2 study, eyes FDA submission By Investing.com
Investing.com· 2 hours agoMIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), a company specializing in neurologic and neuropsychiatric...
Bird flu tests are hard to get. How will we know when to sound the alarm?
NBC Universal via AOL· 2 hours ago“You ran into a testing booth on every other block in Manhattan because companies got $100 every...
How to Know When It’s Time to Swap Antihistamines for Allergy Shots
Self via Yahoo News· 2 hours ago(They’re an eye-watering $800 each, and you need at least one or up to three per visit.) Plus,...
Struggling healthcare company files Chapter 7 bankruptcy
TheStreet via Yahoo Finance· 40 minutes agoThere were no health-related IPOs for more than two years. Through 2023 and into this year, Cue...
FDA Approves Almirall's Klisyri® (tirbanibulin) for the Treatment of Actinic Keratosis on Expanded...
Benzinga· 14 hours agoOriginal FDA approval (December 2020) now extended to the use of Klisyri on larger areas of the face or scalp (up to 100 cm2) to address more extensive manifestations of actinic keratosis, driving convenience for both
How Long Should I Stay on Ozempic For Weight Loss?
MediaFeed via AOL· 3 days agoYou know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid answer to this question yet.
FDA reviews MDMA for PTSD treatment; Biden to issue executive order on border policy
KPBS San Diego· 7 days agoA panel of FDA experts starts reviewing clinical trial data today to decide whether to approve the...
12 Unhealthiest Muffin Mixes You Can Buy
Mashed via Yahoo News· 4 hours agoThere is no reason to doubt the Cinnamon Streusel Muffin & Quick Bread Mix...two muffins, the caloric expense is pretty hefty -- a whopping 410 calories....
'We can do better' Donations roll in for 90-year-old veteran working in sweltering heat
USA Today· 3 hours agoIt was 90 degrees in a Winn-Dixie parking lot in metro New Orleans when Karen Swensen spotted...
Oculis sees promise in dry eye disease subgroup, plans phase 3
FierceBiotech· 9 hours agoOculis is forging ahead with its precision medicine approach to treating dry eye disease, outlining...